STOCK MARKET BSE NSE

Ranbaxy Deal: Sun Says No Insider Trading

Published: 10th April 2014 06:00 AM  |   Last Updated: 10th April 2014 01:23 AM   |  A+A-

Sun Pharmaceuticals Ltd on Wednesday denied insider trading charges against Silverstreet Developers LLP — its wholly-owned subsidiary — in the $4 billion deal to acquire Ranbaxy Laboratories Ltd.

It may be noted that early this week, the Mumbai-based firm surpised analysts and markets announcing its decision to fully acquire Ranbaxy in an all stock transaction with a total equity value of $3.2 billion, along with debt of $800 million taking the overall deal value to $4 billion.

The combined entity of Sun Pharma and Ranbaxy creates the 5th largest specialty generics company in the world and the largest pharmaceutical company in India in terms of sales.

As on March, 2014, Silverstreet Developers LLP's holding in Ranbaxy stood at 1.64 per cent. Interestingly, prior to the September quarter of fiscal 2013-14, Silverstreet had no stake in Ranbaxy and by the end of December, 2013 it bought shares of the Gurgaon-based firm aggregating 1.41 per cent stake.

The matter related to purchase of shares of Ranbaxy Laboratories Ltd by Silverstreet Developers LLP does not violate insider trading rules, said Sun Pharma in a statement.

It has been reported that Sudhir V Valia, brother-in-law of Sun Pharma Managing Director Dilip Shanghvi, was one of the partners of Silverstreet Developers LLP.

According to the company, Sudhir Valia is not and was not a partner of Silverstreet Developers LLP when purchase of shares of Ranbaxy Laboratories Ltd was affected by LLP.

“Silverstreet Developers LLP has two partners. Both are 100 per cent subsidiaries of Sun Pharma. Hence, all the benefits flowing from the investment in Ranbaxy shall accrue to Sun Pharma,” Sun added.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

edexworks
flipboard facebook twitter whatsapp